9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines

      research-article
      1 , , 2 , 3 , 4 , 5 , 4 , 5 , 4 , 5 , 2 , 3 , 2 , 3 , 1 , 1 , 6 , 6 , 7 , 7 , 7 , 8 , 8 , 9 , 9 , 9 , 2 , 10 , 11 , 3 , 10 , 10 , 11 , 1 , 1 , 10 , 11
      BMC Medicine
      BioMed Central
      Dengue, Flavivirus, Primary, Post-primary, Immuno-epidemiology, Surveillance, Serology, Philippines

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          In dengue-endemic countries, targeting limited control interventions to populations at risk of severe disease could enable increased efficiency. Individuals who have had their first (primary) dengue infection are at risk of developing more severe secondary disease, thus could be targeted for disease prevention. Currently, there is no reliable algorithm for determining primary and post-primary (infection with more than one flavivirus) status from a single serum sample. In this study, we developed and validated an immune status algorithm using single acute serum samples from reporting patients and investigated dengue immuno-epidemiological patterns across the Philippines.

          Methods

          During 2015/2016, a cross-sectional sample of 10,137 dengue case reports provided serum for molecular (anti-DENV PCR) and serological (anti-DENV IgM/G capture ELISA) assay. Using mixture modelling, we re-assessed IgM/G seroprevalence and estimated functional, disease day-specific, IgG:IgM ratios that categorised the reporting population as negative, historical, primary and post-primary for dengue. We validated our algorithm against WHO gold standard criteria and investigated cross-reactivity with Zika by assaying a random subset for anti-ZIKV IgM and IgG. Lastly, using our algorithm, we explored immuno-epidemiological patterns of dengue across the Philippines.

          Results

          Our modelled IgM and IgG seroprevalence thresholds were lower than kit-provided thresholds. Individuals anti-DENV PCR+ or IgM+ were classified as active dengue infections (83.1%, 6998/8425). IgG− and IgG+ active dengue infections on disease days 1 and 2 were categorised as primary and post-primary, respectively, while those on disease days 3 to 5 with IgG:IgM ratios below and above 0.45 were classified as primary and post-primary, respectively. A significant proportion of post-primary dengue infections had elevated anti-ZIKV IgG inferring previous Zika exposure. Our algorithm achieved 90.5% serological agreement with WHO standard practice. Post-primary dengue infections were more likely to be older and present with severe symptoms. Finally, we identified a spatio-temporal cluster of primary dengue case reporting in northern Luzon during 2016.

          Conclusions

          Our dengue immune status algorithm can equip surveillance operations with the means to target dengue control efforts. The algorithm accurately identified primary dengue infections who are at risk of future severe disease.

          Supplementary information

          Supplementary information accompanies this paper at 10.1186/s12916-020-01833-1.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          The global distribution and burden of dengue

          Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes 1 . For some patients dengue is a life-threatening illness 2 . There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread 3 . The contemporary worldwide distribution of the risk of dengue virus infection 4 and its public health burden are poorly known 2,5 . Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanisation. Using cartographic approaches, we estimate there to be 390 million (95 percent credible interval 284-528) dengue infections per year, of which 96 million (67-136) manifest apparently (any level of clinical or sub-clinical severity). This infection total is more than three times the dengue burden estimate of the World Health Organization 2 . Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help guide improvements in disease control strategies using vaccine, drug and vector control methods and in their economic evaluation. [285]
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Antibody-dependent enhancement of severe dengue disease in humans

            For dengue viruses 1 to 4 (DENV1-4), a specific range of antibody titer has been shown to enhance viral replication in vitro and severe disease in animal models. Although suspected, such antibody-dependent enhancement of severe disease has not been shown to occur in humans. Using multiple statistical approaches to study a long-term pediatric cohort in Nicaragua, we show that risk of severe dengue disease is highest within a narrow range of preexisting anti-DENV antibody titers. By contrast, we observe protection from all symptomatic dengue disease at high antibody titers. Thus, immune correlates of severe dengue must be evaluated separately from correlates of protection against symptomatic disease. These results have implications for studies of dengue pathogenesis and for vaccine development, because enhancement, not just lack of protection, is of concern.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay.

              The dengue (DEN) viruses are positive-strand RNA viruses in the genus Flavivirus. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are important human arboviral diseases caused by infection with one of four closely related but serologically distinct DEN viruses, designated DEN-1, DEN-2, DEN-3, and DEN-4 viruses. All four DEN serotypes are currently co-circulating throughout the subtropics and tropics, and genotypic variation occurs among isolates within a serotype. A real-time quantitative nucleic acid amplification assay has been developed to detect viral RNA of a single DEN virus serotype. Each primer-probe set is DEN serotype specific, yet detects all genotypes in a panel of 7 to 10 representative isolates of a serotype. In single reactions and in fourplex reactions (containing four primer-probe sets in a single reaction mixture), standard dilutions of virus equivalent to 0.002 PFU of DEN-2, DEN-3, and DEN-4 viruses were detected; the limit of detection of DEN-1 virus was 0.5 equivalent PFU. Singleplex and fourplex reactions were evaluated in a panel of 40 viremic serum specimens with 10 specimens per serotype, containing 0.002 to 6,000 equivalent PFU/reaction (0.4 to 1.2 x 10(6) PFU/ml). Viral RNA was detected in all viremic serum specimens in singleplex and fourplex reactions. Thus, this serotype-specific, fourplex real-time reverse transcriptase PCR nucleic acid detection assay can be used as a method for differential diagnosis of a specific DEN serotype in viremic dengue patients and as a tool for rapid identification and serotyping of DEN virus isolates.
                Bookmark

                Author and article information

                Contributors
                Joseph.Biggs1@lshtm.ac.uk
                Journal
                BMC Med
                BMC Med
                BMC Medicine
                BioMed Central (London )
                1741-7015
                27 November 2020
                27 November 2020
                2020
                : 18
                : 364
                Affiliations
                [1 ]GRID grid.8991.9, ISNI 0000 0004 0425 469X, Department of Infection Biology, Faculty of Infectious and Tropical Diseases, , London School of Hygiene and Tropical Medicine, ; London, UK
                [2 ]GRID grid.437564.7, ISNI 0000 0004 4690 374X, Department of Virology, , Research Institute for Tropical Medicine, ; Manila, Philippines
                [3 ]GRID grid.437564.7, ISNI 0000 0004 4690 374X, Dengue Study Group, , Research Institute for Tropical Medicine, ; Manila, Philippines
                [4 ]GRID grid.8991.9, ISNI 0000 0004 0425 469X, Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, , London School of Hygiene and Tropical Medicine, ; London, UK
                [5 ]GRID grid.8991.9, ISNI 0000 0004 0425 469X, Centre for the Mathematical Modelling of Infectious Diseases, , London School of Hygiene and Tropical Medicine, ; London, UK
                [6 ]GRID grid.490643.c, Philippine Epidemiology Bureau, , Department of Health, ; Manila, Philippines
                [7 ]Pasteur Institute of Nha Trang, Nha Trang, Vietnam
                [8 ]GRID grid.419597.7, ISNI 0000 0000 8955 7323, National Institute of Hygiene and Epidemiology, ; Hanoi, Vietnam
                [9 ]GRID grid.174567.6, ISNI 0000 0000 8902 2273, Paediatric Infectious Diseases Department, Institute of Tropical Medicine, , Nagasaki University, ; Nagasaki, Japan
                [10 ]GRID grid.11159.3d, ISNI 0000 0000 9650 2179, Institute of Human Genetics, National Institute of Health, , University of the Philippines, ; Manila, Philippines
                [11 ]GRID grid.11159.3d, ISNI 0000 0000 9650 2179, Philippine Genome Centre, , University of the Philippines, ; Manila, Philippines
                Author information
                http://orcid.org/0000-0001-7273-874X
                Article
                1833
                10.1186/s12916-020-01833-1
                7694902
                33243267
                641732c8-7f7d-4f93-af39-5e1a5744d806
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 14 August 2020
                : 29 October 2020
                Funding
                Funded by: Royal Society
                Award ID: CHG\R1\170061
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2020

                Medicine
                dengue,flavivirus,primary,post-primary,immuno-epidemiology,surveillance,serology,philippines
                Medicine
                dengue, flavivirus, primary, post-primary, immuno-epidemiology, surveillance, serology, philippines

                Comments

                Comment on this article